EMEA-001825-PIP01-15-M02

Key facts

Invented name
Symtuza
Active substance
  • darunavir
  • cobicistat
  • emtricitabine
  • tenofovir alafenamide
Therapeutic area
Infectious diseases
Decision number
P/0310/2018
PIP number
EMEA-001825-PIP01-15-M02
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of human immunodeficiency virus type-1 (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
Janssen-Cilag International NV

Tel. + 32 1460 2111
E-mail: contact@janssen-emea.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating